Who owns the QADYNA trademark?

The QADYNA trademark is owned by FoldRx Pharmaceuticals, Inc..

What class is the QADYNA trademark registered in?

The QADYNA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for QADYNA?

The USPTO serial number for QADYNA is 85143129.

What is the registration number for QADYNA?

QADYNA is registered under USPTO registration number 4106454.

Sealvo

Home Search: QADYNAQADYNA #85143129

Back

Updated Oct 9, 2026·26 searches this week

View on USPTO TSDR Find similar marks

QAD

USPTO Trademark Record

ABANDONED

QADYNA

SN 85143129·Reg 4106454·Filed Oct 01, 2010

Owner FoldRx Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

QADYNA (Serial No. 85143129), Registration No. 4106454, is a abandoned US trademark filed on Oct 01, 2010 by FoldRx Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

QADYNA (Reg. #4106454) is an abandoned US trademark that was filed in 2010 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 01, 2010

SERIAL

85143129

REG#

4106454

REGISTERED

Feb 28, 2012

Filing Information

StatusABANDONED

Filing DateOct 01, 2010

Serial Number85143129

Registration No.4106454

Registration DateFeb 28, 2012

Status DateSep 09, 2022

Published for OppositionJan 11, 2011

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlySection 8 AcceptedTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1057328

480Oct 27, 2010

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Nov 30, 2011

First use in commerce: Nov 30, 2011

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

30 events

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Sep 09, 2022

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Feb 28, 2021

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 11, 2018

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Mar 11, 2018

REGISTERED - SEC. 8 (6-YR) ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Mar 11, 2018

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

TEAS SECTION 8 RECEIVED

Feb 20, 2018

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Feb 28, 2017

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Feb 28, 2012

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 26, 2012

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

LAW OFFICE REGISTRATION REVIEW COMPLETED

Jan 25, 2012

LAW OFFICE REGISTRATION REVIEW COMPLETED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 23, 2012

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jan 19, 2012

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Jan 18, 2012

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 18, 2012

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 02, 2011

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 GRANTED

Sep 01, 2011

SOU EXTENSION 1 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 01, 2011

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Aug 30, 2011

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Aug 30, 2011

SOU EXTENSION 1 FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 08, 2011

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 11, 2011

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 11, 2011

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 11, 2011

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 11, 2011

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

ASSIGNED TO LIE

Dec 03, 2010

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Dec 03, 2010

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 09, 2010

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 08, 2010

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Oct 05, 2010

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 05, 2010

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Other Marks by FoldRx Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

THA

THAOS

77557563

FoldRx Pharmaceuticals, Inc.

REGISTERED

FOL

FOLDRX

78904850

FoldRx Pharmaceuticals, Inc.

ABANDONED

FOL

FOLDRX

78904911

FoldRx Pharmaceuticals, Inc.

ABANDONED

INA

INARAR

77964102

FoldRx Pharmaceuticals, Inc.

ABANDONED

Other Marks by Richard A. Friedman

Additional USPTO filings handled by the same attorney of record.

LOG

LogoMark

75724355

REGISTERED

PHO

PHOSPHOLINE IODIDE

72087782

REGISTERED

LOG

LogoMark

77038147

REGISTERED

MVI

M.V.I.

73119313

REGISTERED

QADYNA

Run a conflict check

Other Marks by FoldRx Pharmaceuticals, Inc.

Other Marks by Richard A. Friedman

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company